You just read:

Bolt Biotherapeutics Presents Preclinical Data Showing Eradication of Large Resistant Tumors with ISAC Monotherapy at SITC 2019

News provided by

Bolt Biotherapeutics, Inc.

Nov 09, 2019, 08:00 ET